MCkesson equity, debt and subsidaries

Accuracy score :
97%

McKesson Corp  MCK

Summary (from latest annual report – 2016, fiscal year ends in March)

  • Total equity: 8.92 billion USD
  • Market Cap is 38 billion USD ( last price of the stock is 168.83 USD)
  • McKesson Corporation is an American company distributing pharmaceuticals at a retail sale level and providing health information technology, medical supplies, and care management tools
  • Equity of total company increased from 8.01 billion USD in 2015 to 8.92 billion in 2016
  • Company has 4.04 billion USD in cash on account (from latest annual report2016 year)
  • Total equity – cash on account = 8.92 billion USD – 4.04 billion USD = 4.88 billion USD
  • MCK has 3.72 billion USD treasury stock
  • In 2016 company has 6.53 billion USD long-term debt, short – term debt was 1.61 billion USD(In 2015 company had 1.66 billion USD short-term debt , long-term debt was 8.18 billion USD)
  • In latest annual report - total equity increased to 8.92 billion  USD from 8.01 billion USD in 2015, total debt was 8.14 billion USD in 2016)
  • Company's revenue increased in 2016 to 190.88 billion USD from 179.04 billion in 2015
  • Net income in 2016 was 2.25 billion USD, Net income in 2015 was 1.47 billion USD
  • In 2016 company paid 244 million USD dividend to its shareholders

McKesson Corp  Subsidiaries MCK

McKesson Corporation is an American company distributing pharmaceuticals at a retail sale level and providing health information technology, medical supplies, and care management tools. McKesson is based in the United States and distributes health care systems, medical supplies and pharmaceutical products. Additionally, McKesson provides extensive network infrastructure for the health care industry; also, it was an early adopter of technologies like bar-code scanning for distribution, pharmacy robotics, and RFID tags. In addition to its offices throughout North America, McKesson also has international offices in Australia, Ireland, France, the Netherlands, and the United Kingdom. Today, McKesson is one of the oldest continually operating businesses in the United States.

 

McKesson Corp standalone subsidiaries and acquisitions :

 

  • In 1991, McKesson Corporation acquired a 100 percent interest in Medis Health and Pharmaceutical Services for 81 million USD
  • In 1996, McKesson agreed to buy FoxMeyer Health Corp.'s ailing drug unit for 400 million USD
  • In 1999, McKesson Corporation acquired Abaton for 107 million USD
  • In 2005, McKesson acquired Israeli medical technology company Medcon for 105 million USD
  • In 2005, McKesson Corporation acquired regional drug distributor D&K Healthcare Resources Inc. for 207 million USD
  • In 2007, McKesson Corporation acquired software provider Per-Se Technologies for 1.8 billion USD
  • In 2007, McKesson Corporation acquired Oncology Therapeutics Network for 575 million USD
  • In 2008, McKesson Corporation acquired Rosebud Solutions LLC, a provider of software solutions to track and manage instruments, endoscopes and tissue implants for surgical services, as well as medical crash carts and mobile equipment- for undisclosed amount ( less than 50 million USD)
  • In 2008, McKesson Corporation acquired McQueary Brothers Drug Company for 190 million USD
  • In 2010, McKesson acquired leading cancer services company US Oncology, Inc. for 2.16 billion USD, which was integrated into the McKesson Specialty Care Solutions business
  • In 2011 McKesson has announced its acquisition of Portico Systems, which specializes in IT for health plans, for a reported 90 million USD in cash
  • In 2013, McKesson Corporation agreed to acquire PSS World Medical for about 1.62 billion USD to expand in medical supplies and services
  • In October 2013, McKesson agreed to buy a 50% stake in German peer Celesio for 8.3 billion USD
  • In 2015 McKesson has agreed to acquire the pharmaceutical distribution division of Ireland’s UDG Healthcare for 450 million USD
  • In 2016 McKesson has agreed to acquire Vantage Oncology and Biologics for 1.2 billion USD
  • In March 2016, McKesson purchased Canadian pharmacy chain, Rexall, for 2.23 billion USD
  • In period from 2005, McKesson Corporation had several smaller acquisitions : Vivalog Technologies, EN-Chart Scanning Program, peerVue, MedVentive, MED3000, Emendo, Sterling Medical Services, HealthCom Partners, RelayHealth, Practice Partner - worth 700 million USD

 

Total = 20.26 billion usd

Opinion about the company

Fundamentally it is a good company and in the future we can expect its growth (Total debt is big -8.14 billion usd, company has 4.04 billion USD in cash on account, ROE is around 26 %).

 

 

The Reports that you may like

Stock Title % of value Value per share 2018-12-19
(GE) General Electric Co Technical analysis of General Electric 47.92 15.6500 2018-12-17
(zyne) Zyne Calls and Puts - Its usage in investing -256.67 -3.0000 2018-12-12
(GE) General Electric Co General Electric Co GE - equity, debt and subsidiaries 47.92 15.6500 2018-11-26
(zyne) Zyne Three Pillars of Health -256.67 -3.0000 2018-11-27
(zyne) Zyne Prevention instead of treatment in healthcare -256.67 -3.0000 2018-12-09